Results 331 to 340 of about 8,750,628 (402)

Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening

International Journal of Cancer, Volume 158, Issue 5, Page 1348-1360, 1 March 2026.
What's New? While vaccination against high‐risk HPV infection, the primary cause of cervical malignancy, has demonstrated long‐term effectiveness in clinical trials, real‐life longitudinal data are lacking. Here, the authors present linked long‐term screening data on the effectiveness of bivalent HPV vaccination with a minimum follow‐up of 54 months ...
Timothy J. Palmer, Kimberley Kavanagh, Kate Cuschieri, Ross L. Cameron, Catriona Graham, Allan Wilson, Kirsty Roy   +6 more
wiley   +1 more source

Prevalence and genotypic characterization of human papillomavirus in Iraqi women: a retrospective study of 2,193 cases. [PDF]

Virol J
Tahir M, Mohammed D, Sadiq C.
europepmc   +1 more source

Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study

International Journal of Cancer, Volume 158, Issue 5, Page 1361-1369, 1 March 2026.
What's New? Offering the option of self‐sampling in cervical cancer screening programs could increase participation. However, it could also prompt participants to switch from clinician‐collecting sampling, which has demonstrated higher testing sensitivity and lower loss to follow‐up.
Sylvia Kaljouw, Erik E. L. Jansen, Ellen M. G. Olthof, Jan A. C. Hontelez, Inge M. C. M. de Kok   +4 more
wiley   +1 more source

Author Correction: Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology. [PDF]

NPJ Vaccines
Garcea RL, Meinerz NM, Dong M, Funke H, Ghazvini S, Randolph TW.   +5 more
europepmc   +1 more source

Risk of cancer among individuals with a history of bacterial sexually transmitted infections: A population‐based study in Alberta, Canada

International Journal of Cancer, Volume 158, Issue 5, Page 1383-1395, 1 March 2026.
What's New? While previous studies have identified the carcinogenicity of viral agents such as HIV, the role of bacterial sexually transmitted infections in carcinogenesis remains understudied despite them similarly causing chronic inflammation.
Hina M. Qureshi, Taylor Hughes, Eduardo L. Franco, Kirsten M. Fiest, Jennifer Gratrix, Petra A. Smyczek, Ronald Read, Arfan R. Afzal, Rob Deardon, Aliya Kassam, Miranda M. Fidler‐Benaoudia   +10 more
wiley   +1 more source

Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancer. [PDF]

Cell Rep Med
Cao C, Sherman EJ, Riaz N, McBride SM, Yu Y, Shamseddine A, Wong W, Dunn LA, Lee NY.   +8 more
europepmc   +1 more source

Response to A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns. [PDF]

Infect Chemother
Bhattacharya S.
europepmc   +1 more source

TÌNH TRẠNG NHIỄM HUMAN PAPILLOMAVIRUS NGUY CƠ CAO Ở PHỤ NỮ CÓ LOẠN SẢN BIỂU MÔ VẢY CỔ TỬ CUNG ĐỘ CAO

Hạ Long Hải Lê, Kim Đồng Nguyễn, Khánh Huyền Nguyễn, Huy Lượng Vũ   +3 more
openalex   +2 more sources

Profiling Human Papillomavirus Lineage-Specific Capsid Antigenicity With Geographically Diverse Natural Infection Antibodies. [PDF]

J Infect Dis
Panwar K, Yokoya K, Gomes S, Tenet V, Schussler J, Herrero R, Mirabello L, Schiller JT, Sierra MS, Clifford GM, Beddows S.   +10 more
europepmc   +1 more source